110822 ⎘
ssRNA viruses negative-sense; Details; Orthomyxoviridae; Influenzavirus A, i.e. influenza A virus; Methods of production or purification of viral material relating to complementing cells and packaging systems for producing virus or viral particles
MODIFIED INFLUENZA VIRUSES
#2DUCK-DERIVED RNA POLYMERASE I PROMOTER AND RECOMBINANT VECTOR CARRYING SAME
#3INFLUENZA VIRUS HEMAGGLUTININ MUTANTS
#4ATTENUATED ORTHOMYXOVIRUS-BASED VECTOR PLATFORM
#5INFLUENZA VIRUS REPLICATION FOR VACCINE DEVELOPMENT
#6PRODUCTION OF VIRUSES IN CELL CULTURE
#7COMPOSITIONS AND METHODS FOR VIRAL SENSITIZATION
#8RECOMBINANT VIRUS CONTAINING DEGRON, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF
#9Method for adapting influenza viruses to Vero cells
#10Hemagglutinin Modifications for Improved Influenza Vaccine Production
#11Influenza virus replication for vaccine development
#12Suprastructure Comprising Modified Influenza Hemagglutinin With Reduced Interaction With Sialic Acid
#13Influenza virus vectors and uses therefor
#14METHOD FOR PRODUCING REASSORTANT INFLUENZA VIRUSES
#15Whole avian-origin reverse genetic system and recombinant H5N2 subtype avian influenza virus, vaccine and uses thereof
#16Engineered influenza antigenic polypeptides and immunogenic compositions thereof
#17Compositions and methods for viral sensitization
#18Proliferation method
#19Production of viruses in cell culture
#20Heat-resistant H1N1 subtype influenza virus mutant strain, preparation method and application thereof
#21Immunogenic composition against avian influenza virus H5 subtype
#22Influenza virus hemagglutinin mutants
#23INFLUENZA VIRUS HEMAGGLUTINIIN MUTANTS
#24Influenza virus hemagglutinin mutants
#25Method for adapting influenza viruses to Vero cells
#26Influenza virus replication for vaccine development
#27Influenza virus vectors and uses therefor
#28Compositions and methods for viral sensitization
#29SO3 chromatography for use in a method for virus purification
#30Generation of infectious influenza viruses from virus-like particles
#31Engineered influenza antigenic polypeptides and immunogenic compositions thereof
#32INFLUENZA VIRUS REASSORTMENT
#33Engineered cells with decreased gene expression resulting in increased viral production
#34Production of viruses in cell culture
#35Method for the separation of virus compositions including depletion and purification thereof
#36Production of viruses in cell culture
#37High titer recombinant influenza viruses with enhanced replication in vero cells
#38Engineered influenza antigenic polypeptides and immunogenic compositions thereof
#39Recombinant Influenza Viruses for Vaccines and Gene Therapy
#40Methods and compositions related to increased influenza virus production
#41Compositions and methods for enhancing virus replication
#42Compositions and methods for viral sensitization
#43Influenza virus vectors and uses therefor
#44Plasmids and method for obtaining viral particles
#45FORMULATION OF SUGAR SOLUTIONS FOR CONTINUOUS ULTRACENTRIFUGATION FOR VIRUS PURIFICATION
#46Influenza virus reassortment
#47Compositions and methods for increasing immunogenicity of glycoprotein vaccines
#48Recombinant Influenza Viruses for Vaccines and Gene Therapy
#49Influenza virus vectors and uses therefor
#50Influenza virus recombinant proteins
#51Compositions and methods for enhancing virus replication
#52MDCK-derived cell strain suspension-cultured in protein-free medium and method for proliferating virus using cell strain
#53Formulation of sugar solutions for continuous ultracentrifugation for virus purification
#54High titer recombinant influenza viruses with enhanced replication in vero cells
#55Method of replicating viruses in suspension cultures of dog kidney cells
#56Influenza virus reassortment
#57MDCK-derived cell lines adapted to serum-free culture and suspension culture and method for preparing vaccine virus using the cells
#58Influenza virus reassortment method
#59Production of Heterologous Polypeptides in Microalgae, Microalgal Extracellular Bodies, Compositions, and Methods of Making and Uses Thereof
#60AVIAN CELL LINE AND ITS USE IN PRODUCTION OF PROTEIN
#61Method and cells for the production of viral vaccines
#62Pol I promoter derived from Vero cells and recombinant vector containing same
#63Influenza virus reassortment
#64Multi plasmid system for the production of influenza virus
#65MDCK cell lines supporting viral growth to high titers and bioreactor process using the same
#66Influenza virus recombinant proteins
#67Immortalized avian cell lines
#68Multi plasmids system for the production of influenza virus
#69Recombinant influenza viruses for vaccines and gene therapy
#70COMPOSITIONS AND METHODS FOR VACCINE AND VIRUS PRODUCTION
#71Method for generation of RNA virus
#72Production of Heterologous Polypeptides in Microalgae, Microalgal Extracellular Bodies, Compositions, and Methods of Making and Uses Thereof
#73Immortal avian cell line and methods of use
#74RECOMBINANT INFLUENZA VIRUSES FOR VACCINES AND GENE THERAPY
#75High titer recombinant influenza viruses with enhanced replication in vero cells
#76METHOD OF REPLICATING VIRUSES IN SUSPENSION CULTURES OF DOG KIDNEY CELLS
#77Immortalized avian cell lines
#78Formulation of Sugar Solutions for Continuous Ultracentrifugation for Virus Purification
#79Method for generation of RNA virus
#80Compositions and methods for increasing immunogenicity of glycoprotein vaccines
#81Method of purifying influenza virus and removing MDCK cell DNA contaminants
#82RECOMBINANT INFLUENZA VIRUSES FOR VACCINES AND GENE THERAPY
#83Production of vaccines
#84Multi plasmid system for the production of influenza virus
#85Defective Influenza Virus Particles
#86MDCK CELL LINES SUPPORTING VIRAL GROWTH TO HIGH TITERS AND BIOREACTOR PROCESS USING THE SAME
#87Formulation of sugar solutions for continuous ultracentrifugation for virus purification
#88Production of vaccines
#89System producing infectious recombinant influenza virus
#90Recombinant influenza viruses for vaccines and gene therapy
#91Multi plasmid system for the production of influenza virus